Petition for cancer treatment to be funded reaches 46,000 signatories
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago.
A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat.
'Many patients develop tumours in the liver where the treatment could offer significant benefits.
'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.'
The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available.
He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded.
Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: 'Patients are missing out simply because of red tape.
'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.'
Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.'
Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue.
She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.'
An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver.
'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.'
The petition can be found at: change.org/p/ensure-access-for-cancer-patients-to-life-changing-treatment-approved-by-nice.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
20 minutes ago
- Leader Live
ADHD waiting list led to rise in unregulated private providers
The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' A Department of Health and Social Care spokesperson said: 'Lord Darzi's report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis. 'We welcome the publication of the ADHD Taskforce's interim report, which provides valuable insights into the challenges affecting those with ADHD, including access to services and support.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
Leader Live
20 minutes ago
- Leader Live
Chris Hoy calls for systemic change in testing for prostate cancer
The 49-year old cyclist was diagnosed with stage four prostate cancer in 2023 and was told last year that it has spread to his bones and is terminal. NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier. He said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. 'With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got.' One option is a PSA blood test which checks the level of prostate-specific antigens in the blood, A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Sir Chris's comments came after Prostate Cancer UK urged the UK Government for an overhaul of NHS guidelines to encourage GPs to proactively speak to men at high risk from 45 years old. #ProstateCancer has become the most common cancer in England. However, for a disease that affects 1 in 8 men, there's still no screening programme and outdated NHS guidelines prevent lifesaving conversations with men at highest risk. ➡️ Read more: — Prostate Cancer UK (@ProstateUK) January 28, 2025 According to the charity, around one in eight men in the UK will get prostate cancer, which occurs when cells in the prostate start to grow in an uncontrolled way and, if not detected early, risks spreading. Sir Chris added: 'I believe men at highest risk, for example men with a family history like me or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility. 'I've faced many challenges in my life, and going public with my prostate cancer diagnosis was certainly one of them. 'I've been incredibly lucky to have so much support from my family, friends and the general public. The kindness has lifted me up and given me a sense of purpose, and I'm committed to taking that forward and using my platform to raise awareness of the most common cancer in men and help more men at risk to come forward and get tested.' The Scottish cyclist has launched his own charity cycling challenge, Tour de 4, with the aim of changing perceptions around stage four cancer. The challenge will take place on September 7 in Glasgow with a final registration phase open for riders to sign up. Speaking about Sir Chris, Laura Kerby, chief executive at Prostate Cancer UK, said: 'His bravery and tireless work to raise awareness has already made a huge impact. 'In just a few months after Sir Chris went public with his diagnosis last year, over 286,000 people used our online risk checker to learn more about the disease, find out their own risk and learn what they can choose to do about it. 'His bravery has inspired so many men to take action, and he has undoubtedly saved lives. 'One in eight men will get prostate cancer. The earlier it's found, the easier it is to treat — but there's currently no screening programme in the UK. So if, like Sir Chris, you have a family history of the disease, or if you're black, we strongly encourage you to speak to your GP about testing from the age of 45. 'We don't think it's right that the responsibility is all on men's shoulders, so we're calling on the Health Secretary to overhaul outdated NHS guidelines so that GPs are empowered to actually start conversations with these men at highest risk.' The Department for Health and Social Care has been contacted for comment.
Leader Live
20 minutes ago
- Leader Live
Campaigners for and against assisted dying make feelings known at Westminster
Dame Prue Leith, Dame Esther Rantzen's daughter, Rebecca Wilcox, and the broadcaster, Jonathan Dimbleby, were among the high-profile figures supporting the Bill to change the law in England and Wales. Members of the Dignity in Dying campaign wore pink and held placards in memory of friends and family members. Those opposed to the Bill included groups dressed as scientists in white lab coats and bloodied gloves and masks, as well as nuns and other members of religious organisations. The mood amongst campaigners was largely calm and respectful on both sides. Dame Prue told the PA news agency she was 'both nervous and confident' about the outcome. 'It's so moving to see all these people with placards of people they've lost or people who are dying of cancer,' she said. 'It's hard not to cry because I think they have done such a good job. Let's hope we've won.' Mr Dimbleby said he believed the Bill would be 'transformative'. He added: 'What it will mean is millions of people will be able to say to themselves, 'If I'm terminally ill, I will be able to choose, assuming I am of sound mind and I am not being coerced, to say 'Yes, I want to be assisted – I have dignity in death'.' Rebecca Wilcox, the daughter of Dame Esther, said: 'It couldn't be a kinder, more compassionate Bill that respects choice at the end of life, that respects kindness and empathy and gives us all an option when other options, every other option, has been taken away, and it would just be the perfect tool for a palliative care doctor to have in their med bag.' Teachers Catie and Becky Fenner said they wanted other families to benefit from the Bill. Their mother, who had motor neurone disease, had flown to Dignitas in Switzerland to end her life at a cost of £15,000. The sisters said they did not get to properly say goodbye and grieve and worried about the legal repercussions. Catie, 37, said: 'We were left quite traumatised by the whole experience – not only seeing a parent go through a really horrible disease but then the secrecy of the planning.' Campaigners against the Bill, who were gathered outside Parliament, chanted 'We are not dead yet' and 'Kill the Bill, not the ill'. A display was erected with a gravestone reading 'RIP: The Terminally Ill Adults (End of Life) Bill. Bury it deep', and behind were two mounds meant to resemble graves. Andrew Hilliard, 75, said he was opposed for religious reasons. He was dressed in a white lab coat with a placard reading: 'Protect our NHS from becoming the National Suicide Service'. The chief executive of Care Not Killing, Dr Gordon Macdonald, said MPs should prioritise improving palliative care. He said: 'Most people, when thinking about the practical implications of this, for those most vulnerable, they change their minds.' George Fielding, a campaigner affiliated with the Not Dead Yet group which is opposed to assisted dying, said he attended to represent disabled people. He said: 'This Bill will endanger and shorten the lives of disabled people.'
